YOR073W-A Antibody

What is YOR073W-A and what cellular functions is it associated with?

YOR073W-A is a protein-coding gene in Saccharomyces cerevisiae (baker's yeast), which has become an important target for various research applications in molecular biology and genetics. The gene encodes a protein that functions within cellular pathways related to stress response mechanisms. Understanding the protein's function provides critical context for designing experiments that utilize antibodies targeting this protein. Recent research suggests potential roles in cellular adaptation to environmental stressors, though complete functional characterization remains an active area of investigation. When utilizing YOR073W-A antibodies, researchers should consider the protein's subcellular localization and expression patterns throughout different growth phases to optimize experimental design.

What are the key specifications of commercially available YOR073W-A antibodies?

YOR073W-A antibodies are typically developed as polyclonal or monoclonal reagents designed to recognize specific epitopes of the yeast protein. Based on available research-grade products, most YOR073W-A antibodies are produced in rabbit host systems and optimized for applications including western blotting, immunoprecipitation, and immunofluorescence microscopy. The antibody referenced in search results (catalog number CSB-PA314395XA01SVG-10mg) represents a research-grade reagent available in 10mg quantity configurations . Researchers should verify specifications including:

• Antibody class (IgG is most common for research applications)

• Clonality (polyclonal or monoclonal)

• Recognized epitope region (N-terminal, C-terminal, or internal domains)

• Validated applications (WB, IP, IF, ELISA, etc.)

• Cross-reactivity with homologous proteins in other species

How should YOR073W-A antibody be stored and handled to maintain optimal activity?

Proper storage and handling of YOR073W-A antibody is essential for maintaining its specificity and sensitivity. Based on standard antibody protocols similar to those used for other research antibodies, the following recommendations apply:

• Store lyophilized antibody at -20°C to -70°C until reconstitution

• After reconstitution, store at 2-8°C for short-term use (approximately 1 month)

• For long-term storage, prepare small aliquots and store at -20°C to -70°C

• Avoid repeated freeze-thaw cycles which can damage antibody structure and function

• Use sterile techniques when handling reconstituted antibody solutions

• Follow manufacturer's specific buffer recommendations for dilution

Similar to protocols established for other research antibodies, YOR073W-A antibody likely maintains optimal activity for up to 12 months from receipt date when stored properly at -20°C to -70°C, with reduced stability (1 month) under refrigeration after reconstitution .

What are the recommended validation methods for confirming YOR073W-A antibody specificity?

Confirming antibody specificity is a critical step before conducting major experiments. For YOR073W-A antibody, researchers should implement multiple validation strategies:

• Positive and negative controls: Use wild-type yeast extracts as positive control and YOR073W-A knockout strain extracts as negative control

• Western blot analysis: Verify single band of expected molecular weight

• Immunoprecipitation followed by mass spectrometry: Confirm target protein identity

• Signal inhibition: Pre-incubation with immunizing peptide should abolish signal

• Cross-validation with orthogonal detection methods: Compare with fluorescent protein tags or RNA expression data

Validation should ideally incorporate multiple techniques to establish antibody specificity under various experimental conditions. This approach mirrors validation protocols used for other antibodies in immunological research, where demonstration of specific binding is paramount before conducting extensive experimental work .

How can YOR073W-A antibody be optimized for immunofluorescence microscopy applications?

Optimizing YOR073W-A antibody for immunofluorescence applications requires careful attention to several methodological factors:

• Fixation protocol: Test both formaldehyde (4%) and methanol fixation methods to determine which best preserves the epitope while maintaining cellular architecture

• Permeabilization conditions: For yeast cells, evaluate enzymatic cell wall digestion (zymolyase treatment) followed by gentle detergent permeabilization (0.1-0.5% Triton X-100)

• Blocking parameters: Use 3-5% BSA or normal serum from the secondary antibody host species

• Antibody dilution series: Test a range of dilutions (typically 1:100 to 1:1000) to determine optimal signal-to-noise ratio

• Incubation conditions: Compare room temperature (1-2 hours) versus 4°C overnight incubation

• Secondary antibody selection: Choose fluorophores based on microscopy system specifications and avoid spectral overlap with other fluorescent markers

Researchers should conduct preliminary dilution series experiments to identify optimal antibody concentrations, similar to protocols established for membrane-associated protein detection using flow cytometry and immunofluorescence techniques .

What strategies are effective for using YOR073W-A antibody in co-immunoprecipitation studies?

Co-immunoprecipitation (Co-IP) with YOR073W-A antibody requires careful optimization to maintain protein-protein interactions while achieving efficient target capture:

• Lysis buffer optimization: Use gentle, non-denaturing buffers containing 0.5-1% NP-40 or Triton X-100, with physiological salt concentrations (150mM NaCl)

• Pre-clearing lysates: Remove non-specific binding proteins using protein A/G beads before adding the antibody

• Antibody coupling strategies: Compare direct antibody addition versus pre-coupling to beads

• Incubation parameters: Optimize incubation time (2-16 hours) and temperature (4°C is standard)

• Washing stringency: Balance between removing non-specific interactions while preserving genuine interactions

• Elution methods: Compare different elution strategies (low pH, competition with peptide, SDS)

For detection of novel protein interactions, researchers should consider implementing crosslinking protocols before lysis, particularly if interactions are transient or weak. This approach has been successful in characterizing protein complexes in immunological studies of other systems .

How can YOR073W-A antibody be used to investigate stress-induced protein modifications?

Investigating stress-induced modifications of YOR073W-A protein requires specialized approaches leveraging antibody-based detection:

• Stress induction protocols: Establish time-course experiments exposing yeast cultures to relevant stressors (oxidative, osmotic, nutrient depletion)

• Modification-specific detection: Combine YOR073W-A antibody with antibodies recognizing specific post-translational modifications (phosphorylation, ubiquitination, SUMOylation)

• Two-dimensional gel electrophoresis: Separate protein isoforms prior to western blotting

• Immunoprecipitation coupled with mass spectrometry: Identify specific modifications and their sites

• Comparison of mutant strains: Analyze modification patterns in relevant kinase or phosphatase deletion strains

The following table outlines a suggested experimental design for investigating stress-induced modifications:

This experimental approach builds on methodologies used to study other stress-responsive proteins in yeast and mammalian systems, adapted specifically for YOR073W-A investigations.

What are the considerations for using YOR073W-A antibody in chromatin immunoprecipitation studies?

If YOR073W-A has nuclear functions or chromatin associations, ChIP studies require specific optimization:

• Crosslinking optimization: Test various formaldehyde concentrations (0.5-3%) and incubation times (5-20 minutes)

• Chromatin fragmentation: Compare sonication and enzymatic digestion methods to generate 200-500bp fragments

• Antibody specificity verification: Perform ChIP in YOR073W-A deletion strains as negative controls

• Input normalization: Carefully quantify and normalize to input chromatin

• Primer design for qPCR validation: Design primers for putative binding regions and negative control regions

• Next-generation sequencing considerations: Address library preparation challenges with low-yield samples

Researchers should develop positive controls by testing regions expected to show enrichment based on existing literature about YOR073W-A function or related proteins. This approach aligns with methods used for studying idiotypic networks and antibody-based chromatin profiling in other systems .

How can researchers address non-specific binding issues with YOR073W-A antibody?

Non-specific binding represents a common challenge in antibody-based experiments. For YOR073W-A antibody applications, implement these troubleshooting approaches:

• Blocking optimization: Test different blocking agents (BSA, casein, normal serum) and concentrations (1-5%)

• Antibody dilution adjustment: Increase dilution ratio to reduce background

• Detergent concentration: Add 0.1-0.5% Tween-20 to washing buffers

• Pre-adsorption protocol: Pre-incubate antibody with control lysates from YOR073W-A deletion strains

• Secondary antibody controls: Perform controls with secondary antibody only

• Cross-reactivity assessment: Test antibody against purified proteins with similar sequences

For persistent non-specific binding issues, consider immunoaffinity purification of the antibody against the specific epitope. This process increases specificity by selecting only antibodies that bind the target epitope, similar to methods used for purifying other antibodies used in research applications .

What approaches should be used when interpreting contradictory results between YOR073W-A antibody-based detection and other methods?

When facing contradictory results between antibody-based detection and other methods (e.g., mRNA levels, tagged constructs), implement a systematic analysis approach:

• Epitope accessibility assessment: Determine if protein conformations or interactions might mask the epitope

• Post-translational modification influence: Evaluate if modifications affect antibody recognition

• Protein turnover considerations: Compare protein half-life with mRNA stability

• Subcellular localization differences: Investigate if compartmentalization influences detection

• Method-specific artifacts: Identify potential artifacts specific to each method

• Quantification normalization: Ensure appropriate normalization controls for each method

How can YOR073W-A antibody be adapted for super-resolution microscopy techniques?

Adapting YOR073W-A antibody for super-resolution microscopy requires specific considerations:

• Secondary antibody selection: Choose secondary antibodies conjugated with bright, photostable fluorophores compatible with the intended super-resolution technique (Alexa Fluor 647 for STORM/PALM, ATTO dyes for STED)

• Fixation optimization: Test different fixation protocols that preserve spatial organization at nanoscale resolution

• Antibody fragment adaptation: Consider using F(ab) or nanobody derivatives for improved spatial resolution

• Multi-color imaging strategy: Develop labeling protocols compatible with simultaneous imaging of other cellular structures

• Sample mounting media: Use specialized anti-fade media with appropriate refractive index

• Drift correction: Implement fiducial markers for drift correction during long acquisitions

Researchers should validate super-resolution imaging results against conventional microscopy data and correlate with functional assays to ensure biological relevance of the observed nanoscale distributions. This approach draws on methods used for high-resolution imaging of membrane proteins and cellular structures in other research contexts .

What are the emerging applications of YOR073W-A antibody in understanding cellular stress response networks?

Emerging applications of YOR073W-A antibody in stress response research include:

• Proximity-dependent labeling: Combining antibody-based pulldowns with BioID or APEX2 approaches to map interaction networks under different stress conditions

• Single-cell proteomics integration: Using antibody-based flow cytometry or mass cytometry to analyze cell-to-cell variation in YOR073W-A expression and modification

• Microfluidic applications: Implementing antibody-based detection in microfluidic devices for real-time monitoring of stress responses

• Computational modeling integration: Using quantitative antibody-based data to constrain and validate computational models of stress response networks

• Evolutionary conservation analysis: Applying the antibody to study functionally conserved stress response mechanisms across fungal species

These emerging approaches build upon methodological foundations established in multispecific antibody research, where complex interaction networks can be mapped through careful experimental design and antibody-based detection systems .